NANOBIOTIX' Management Statement on Recent Share Price Variation
- Written by ACN Newswire
Paris, France and Cambridge, Massachusetts, USA, Jun 6, 2018 - (ACN Newswire) - NANOBIOTIX (Euronext: NANO - ISIN: FR0011341205), a late clinical-stage nanomedicine company pioneering new approaches to the treatment of cancer, communicates today regarding the recent evolution of its share price.The Company noticed a significant decrease of its...